Healthcare Utilization Amongst Patients with NSCLC Before and After Testing with a Host Immune Classifier (HIC) in a Real-World Setting

被引：0
|
作者：
Iams, Wade [1 ]
Le, Kimberly [2 ]
Princic, Nicole [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Biodesix Inc, Boulder, CO USA
[3] Merative, Ann Arbor, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.13
引用
收藏
页码：E13 / E14
页数：2
相关论文
共 50 条
  • [1] Healthcare Utilization Amongst Patients with NSCLC Stratified by Metastatic Status Before and After Testing with a Host Immune Classifier (HIC)
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E14 - E14
  • [2] Evaluation of Lines of Therapy Amongst Patients with NSCLC Tested with a Host Immune Classifier (HIC) in a Real-World Setting
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E14 - E15
  • [3] Real-world healthcare resource utilization amongst non-small cell lung cancer (NSCLC) patients tested with a host immune classifier (HIC)
    Iams, Wade Thomas
    Le, Kimberly
    Princic, Nicole
    Marlin, Taylor
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Healthcare Costs Amongst Patients with Non-Small Cell lung cancer (NSCLC) Before and After Testing with a Host Immune Classifier (HIC)
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E14 - E14
  • [5] Real-world healthcare costs amongst non-small cell lung cancer (NSCLC) patients tested with a host immune classifier (HIC)
    Iams, Wade Thomas
    Le, Kimberly
    Princic, Nicole
    Marlin, Taylor
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Real-world demographics, baseline characteristics, healthcare resource utilization and costs amongst non-small cell lung cancer (NSCLC) patients tested with a Host Immune Classifier (HIC)
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    Winer, Isabelle
    Marlin, Taylor
    CANCER RESEARCH, 2023, 83 (07)
  • [7] ANALYSIS OF IMMUNE RELATED ADVERSE EVENTS IN NSCLC PATIENTS RECEIVING DURVALUMAB AFTER CHEMORADIOTHERAPY IN THE REAL-WORLD CLINICAL SETTING
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Nakatani, Koichi
    Mio, Tadashi
    RESPIROLOGY, 2019, 24 : 50 - 50
  • [8] Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting
    Ai, Xinghao
    Yu, Yongfeng
    Zhao, Jun
    Sheng, Wang
    Bai, Jing
    Fan, Zaiwen
    Liu, Xuemei
    Ji, Wenxiang
    Chen, Rongrong
    Lu, Shun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [9] Use of Intravenous Immune Globulin in Patients with Immune Thrombocytopenia Before and After Romiplostim: Real-World Experience
    Hamilton, Korinne
    Toltl, Lisa J.
    Wang, Grace
    Sholapur, Naushin S.
    Carruthers, Julie
    Hsia, Cyrus C.
    Hamm, Caroline
    Blais, Normand
    Girard-Desbiens, Catherine
    Pearson, Marc-Andre
    Heddle, Nancy
    Arnold, Donald M.
    BLOOD, 2012, 120 (21)
  • [10] Real-World Genetic Testing Utilization Among Patients With Cardiomyopathy
    Morales, Ana
    Moretz, Chad
    Ren, Sheng
    Smith, Elizabeth
    Callis, Thomas E.
    Hall, Taryn
    Hatchell, Kathryn E.
    Nussbaum, Robert L.
    Regalado, Ellen
    Rojahn, Susan
    Vatta, Matteo
    Esplin, Edward D.
    Murillo, Jaime
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2024, 17 (01):
12345